Abbott Laboratories (ABT) Assets Average (2009 - 2026)

Abbott Laboratories has disclosed Assets Average across 18 years of filings, most recently posting $109.8 billion for Q2 2026.

• In Q2 2026, Assets Average rose 32.76% year-over-year to $109.8 billion; the TTM figure through Jun 2026 stood at $109.8 billion (up 32.76% YoY), while the FY2025 annual figure was $84.1 billion, up 8.73% from the prior year.
• Assets Average came in at $109.8 billion for Q2 2026 at Abbott Laboratories, up from $98.6 billion in the prior quarter.
• In the past five years, Assets Average ranged from a high of $109.8 billion in Q2 2026 to a low of $72.7 billion in Q4 2023.
• Average Assets Average over 5 years is $79.3 billion, with a median of $74.1 billion recorded in 2022.
• Year-over-year, Assets Average retreated 1.72% in 2024 and jumped 32.76% in 2026.
• Over 5 years, Assets Average stood at $73.6 billion in 2022, then dropped by 1.31% to $72.7 billion in 2023, then advanced by 7.2% to $77.9 billion in 2024, then advanced by 9.71% to $85.4 billion in 2025, then increased by 28.53% to $109.8 billion in 2026.
• Per Business Quant data, the three most recent Assets Average figures were $109.8 billion in Q2 2026, $98.6 billion in Q1 2026, and $85.4 billion in Q4 2025.